Gavi
@gavi.org
Gavi, the Vaccine Alliance helps vaccinate half the world’s children against deadly and debilitating diseases. #VaccinesWork #ForOurFuture
Pinned
Hi Bluesky! 👋
For 25 years we’ve worked to protect over 1.2 billion children from preventable diseases and today we help provide vaccines for half the world’s children.
Follow us for science-backed health stories, global health insights and daily proof that #VaccinesWork. 💪
For 25 years we’ve worked to protect over 1.2 billion children from preventable diseases and today we help provide vaccines for half the world’s children.
Follow us for science-backed health stories, global health insights and daily proof that #VaccinesWork. 💪
Ever heard of Oropouche virus? Or chikungunya virus? There’s a reason infectious disease experts are watching these viral threats closely in 2026: bit.ly/4qFWmuP Via The Conversation
Viral outbreaks are always on the horizon – here are the viruses an infectious disease expert is watching in 2026
Viral infections are on the rise and spreading across the globe.
bit.ly
January 10, 2026 at 7:00 AM
Ever heard of Oropouche virus? Or chikungunya virus? There’s a reason infectious disease experts are watching these viral threats closely in 2026: bit.ly/4qFWmuP Via The Conversation
This seemingly ordinary bus is actually a highly sophisticated mobile laboratory that’s investigating unknown pathogens across India. Here’s how this advanced “space shuttle” is equipped to investigate and contain deadly outbreaks: bit.ly/4qabhxv
This Indian bus is actually a high-security mobile laboratory
From the plains of Uttar Pradesh to cloud-skimming Himalayan villages, RAMBAAN, a Biosafety Level 3 lab on wheels, is chasing down the next big, bad bug.
bit.ly
January 9, 2026 at 7:02 PM
This seemingly ordinary bus is actually a highly sophisticated mobile laboratory that’s investigating unknown pathogens across India. Here’s how this advanced “space shuttle” is equipped to investigate and contain deadly outbreaks: bit.ly/4qabhxv
Turning ideas into products that improve health takes more than talent.
A new partnership in Egypt aims to strengthen biotech education and innovation across the Middle East and Africa, addressing a persistent disconnect between academia and industry.
bit.ly/3N8QfAU
A new partnership in Egypt aims to strengthen biotech education and innovation across the Middle East and Africa, addressing a persistent disconnect between academia and industry.
bit.ly/3N8QfAU
Egypt partnership targets African biotech academy
American University in Cairo looks to establish ‘first African academy for biotechnology.
bit.ly
January 9, 2026 at 3:01 PM
Turning ideas into products that improve health takes more than talent.
A new partnership in Egypt aims to strengthen biotech education and innovation across the Middle East and Africa, addressing a persistent disconnect between academia and industry.
bit.ly/3N8QfAU
A new partnership in Egypt aims to strengthen biotech education and innovation across the Middle East and Africa, addressing a persistent disconnect between academia and industry.
bit.ly/3N8QfAU
Read the full article to dive deeper into these vaccine breakthroughs and what they mean for global health over the year ahead: bit.ly/3YnAcBJ
What are the biggest vaccine breakthroughs coming in 2026? We asked five experts
From mRNA to HIV, we asked five vaccine leaders to share the advances they believe will shape global health in 2026.
bit.ly
January 9, 2026 at 10:17 AM
Read the full article to dive deeper into these vaccine breakthroughs and what they mean for global health over the year ahead: bit.ly/3YnAcBJ
“The growing importance of locally produced vaccines for locally relevant infectious diseases is exemplified by Biovac’s oral cholera vaccine entering a clinical trial – a first for end-to-end cholera vaccine production in Africa.”
January 9, 2026 at 10:17 AM
“The growing importance of locally produced vaccines for locally relevant infectious diseases is exemplified by Biovac’s oral cholera vaccine entering a clinical trial – a first for end-to-end cholera vaccine production in Africa.”
“Following the unprecedented success of mRNA-based COVID-19 vaccines, this platform has become a central focus of HIV vaccine research, offering a promising approach to induce robust and targeted immune responses."
January 9, 2026 at 10:17 AM
“Following the unprecedented success of mRNA-based COVID-19 vaccines, this platform has become a central focus of HIV vaccine research, offering a promising approach to induce robust and targeted immune responses."
"In 2025, we saw the publication of remarkable rotavirus vaccine effectiveness data from India with the Indian-made Rotavac vaccine. In 2026, we should get results from the second Indian vaccine, Rotasiil.” @gatesfoundation.bsky.social
January 9, 2026 at 10:17 AM
"In 2025, we saw the publication of remarkable rotavirus vaccine effectiveness data from India with the Indian-made Rotavac vaccine. In 2026, we should get results from the second Indian vaccine, Rotasiil.” @gatesfoundation.bsky.social
“In 2026, further implementation of the safe and effective pre-F fusion vaccine against respiratory syncytial virus (RSV), which is administered to pregnant women and protects young infants, should be a priority.” @lshtm.bsky.social
January 9, 2026 at 10:17 AM
“In 2026, further implementation of the safe and effective pre-F fusion vaccine against respiratory syncytial virus (RSV), which is administered to pregnant women and protects young infants, should be a priority.” @lshtm.bsky.social
"Messenger RNA (mRNA) [vaccine] platforms are expanding beyond their initial applications, opening new possibilities for neglected and emerging infectious disease prevention and even therapeutic interventions."
January 9, 2026 at 10:17 AM
"Messenger RNA (mRNA) [vaccine] platforms are expanding beyond their initial applications, opening new possibilities for neglected and emerging infectious disease prevention and even therapeutic interventions."
What vaccine breakthroughs are coming in 2026?
We asked 5 leading experts to share the innovations in immunisation they believe will shape global health this year.
Here are the key advances to watch 🧵👇
We asked 5 leading experts to share the innovations in immunisation they believe will shape global health this year.
Here are the key advances to watch 🧵👇
January 9, 2026 at 10:17 AM
What vaccine breakthroughs are coming in 2026?
We asked 5 leading experts to share the innovations in immunisation they believe will shape global health this year.
Here are the key advances to watch 🧵👇
We asked 5 leading experts to share the innovations in immunisation they believe will shape global health this year.
Here are the key advances to watch 🧵👇
Here’s how fathers are bucking gender stereotypes to champion immunisation in Kenya’s Samburu region:
bit.ly/3LkkGna
bit.ly/3LkkGna
In Kenya’s Samburu, fathers buck gender stereotypes to champion immunisation
Traditionally children’s health is a mother’s domain – but this group of dads argues that vaccination is part and parcel of a very masculine tradition of protection.
bit.ly
January 9, 2026 at 7:00 AM
Here’s how fathers are bucking gender stereotypes to champion immunisation in Kenya’s Samburu region:
bit.ly/3LkkGna
bit.ly/3LkkGna
These fathers reframed vaccination as a modern extension of their tradition of protection. Using their knowledge of migration patterns, the fathers help locate families with unvaccinated children.
January 9, 2026 at 7:00 AM
These fathers reframed vaccination as a modern extension of their tradition of protection. Using their knowledge of migration patterns, the fathers help locate families with unvaccinated children.
“We protect cattle fiercely. But we realised we were not doing the same for our children."
In Kenya’s Samburu County, 18% of children are unvaccinated – double the national rate. Now, a grassroots group of fathers is stepping up to change that.
In Kenya’s Samburu County, 18% of children are unvaccinated – double the national rate. Now, a grassroots group of fathers is stepping up to change that.
January 9, 2026 at 7:00 AM
“We protect cattle fiercely. But we realised we were not doing the same for our children."
In Kenya’s Samburu County, 18% of children are unvaccinated – double the national rate. Now, a grassroots group of fathers is stepping up to change that.
In Kenya’s Samburu County, 18% of children are unvaccinated – double the national rate. Now, a grassroots group of fathers is stepping up to change that.
From 2021 to 2025, immunisation faced some of its biggest tests and delivered some of its most significant wins yet.
Here's how we worked with countries, partners and communities to protect millions of children through it all: bit.ly/3N6LJCS
Here's how we worked with countries, partners and communities to protect millions of children through it all: bit.ly/3N6LJCS
January 8, 2026 at 7:01 PM
From 2021 to 2025, immunisation faced some of its biggest tests and delivered some of its most significant wins yet.
Here's how we worked with countries, partners and communities to protect millions of children through it all: bit.ly/3N6LJCS
Here's how we worked with countries, partners and communities to protect millions of children through it all: bit.ly/3N6LJCS
"When I heard the song, it directed the message to me, as it said, you, mother, take your child for immunisation." A Kenyan mother explains how a choir's vaccine song changed her mind about taking her children to get their shots. bit.ly/4ppIsMw
"Singing is praying" – how a choir in Turkana, Kenya, spread the word about immunisation
Music carries, say the Turkana public health officials fighting to close post-COVID-19 immunity gaps.
bit.ly
January 8, 2026 at 5:01 PM
"When I heard the song, it directed the message to me, as it said, you, mother, take your child for immunisation." A Kenyan mother explains how a choir's vaccine song changed her mind about taking her children to get their shots. bit.ly/4ppIsMw
What has underpinned Gavi’s success over the past 25 years and what can it teach us about adapting multilateralism for a rapidly changing world? Read former Gavi Board Chair José Manuel Barroso’s op-ed to find out: bit.ly/45rn5TK Via Project Syndicate
A Model to Keep Multilateralism Alive
José Manuel Barroso reflects on what has made Gavi so successful, even as other international organizations have become paralyzed.
bit.ly
January 8, 2026 at 11:01 AM
What has underpinned Gavi’s success over the past 25 years and what can it teach us about adapting multilateralism for a rapidly changing world? Read former Gavi Board Chair José Manuel Barroso’s op-ed to find out: bit.ly/45rn5TK Via Project Syndicate
What vaccine breakthroughs are coming in 2026? We asked 5 leading experts to share the innovations that will shape global health this year — from new HIV vaccine approaches to expanding manufacturing in Africa and Latin America.
Read what's ahead: bit.ly/3YnAcBJ
Read what's ahead: bit.ly/3YnAcBJ
What are the biggest vaccine breakthroughs coming in 2026? We asked five experts
From mRNA to HIV, we asked five vaccine leaders to share the advances they believe will shape global health in 2026.
bit.ly
January 7, 2026 at 11:01 AM
What vaccine breakthroughs are coming in 2026? We asked 5 leading experts to share the innovations that will shape global health this year — from new HIV vaccine approaches to expanding manufacturing in Africa and Latin America.
Read what's ahead: bit.ly/3YnAcBJ
Read what's ahead: bit.ly/3YnAcBJ
The hepatitis B “birth dose” protects newborns from a chronic, liver-damaging infection, but the jab’s 24-hour window of opportunity leaves little room for logistical inefficiency.
Here’s how a new project in Nigeria’s Delta State may have cracked the timeliness code. bit.ly/498T0e0
Here’s how a new project in Nigeria’s Delta State may have cracked the timeliness code. bit.ly/498T0e0
Pilot programme massively boosts hepatitis B “birth dose” vaccination in Nigeria’s Delta state
The hepatitis B “birth dose” protects newborns from chronic, liver-killing infection, but the jab’s 24-hour window of opportunity leaves little room for logistical inefficiency. A new project in…
bit.ly
January 6, 2026 at 7:30 PM
The hepatitis B “birth dose” protects newborns from a chronic, liver-damaging infection, but the jab’s 24-hour window of opportunity leaves little room for logistical inefficiency.
Here’s how a new project in Nigeria’s Delta State may have cracked the timeliness code. bit.ly/498T0e0
Here’s how a new project in Nigeria’s Delta State may have cracked the timeliness code. bit.ly/498T0e0
All flus are not created equal.
Take Subclade K. First spotted in Norway, it caused the UK's flu season to start 4-5 weeks earlier than usual and has been dominating headlines ever since.
But is it a “superflu”? Science writer Linda Geddes explores on our Vaccines Work platform: bit.ly/3N5nR2D
Take Subclade K. First spotted in Norway, it caused the UK's flu season to start 4-5 weeks earlier than usual and has been dominating headlines ever since.
But is it a “superflu”? Science writer Linda Geddes explores on our Vaccines Work platform: bit.ly/3N5nR2D
January 6, 2026 at 5:30 PM
All flus are not created equal.
Take Subclade K. First spotted in Norway, it caused the UK's flu season to start 4-5 weeks earlier than usual and has been dominating headlines ever since.
But is it a “superflu”? Science writer Linda Geddes explores on our Vaccines Work platform: bit.ly/3N5nR2D
Take Subclade K. First spotted in Norway, it caused the UK's flu season to start 4-5 weeks earlier than usual and has been dominating headlines ever since.
But is it a “superflu”? Science writer Linda Geddes explores on our Vaccines Work platform: bit.ly/3N5nR2D
As 2025 comes to a close, Dr Emmanuel Mugisha with the Coalition Against Typhoid reflects on the incredible progress on typhoid control accomplished this year: bit.ly/48ZDDDi
Reaching 80 million children with typhoid conjugate vaccines
As 2025 comes to a close, Dr. Emmanuel Mugisha reflects on the incredible progress on typhoid control accomplished this year.
bit.ly
January 2, 2026 at 2:01 PM
As 2025 comes to a close, Dr Emmanuel Mugisha with the Coalition Against Typhoid reflects on the incredible progress on typhoid control accomplished this year: bit.ly/48ZDDDi
This supports continued vaccination programs and demonstrates why investment in population health monitoring delivers critical insights.
Read more: bit.ly/4ot4sq9
Read more: bit.ly/4ot4sq9
COVID-19 infection poses higher, longer heart risks to children than vaccination
A comprehensive analysis of English health records finds higher risk of rare heart complications in children and adolescents who caught COVID-19 compared to those who received an mRNA-based COVID…
bit.ly
December 30, 2025 at 11:01 AM
This supports continued vaccination programs and demonstrates why investment in population health monitoring delivers critical insights.
Read more: bit.ly/4ot4sq9
Read more: bit.ly/4ot4sq9
"These complications are really rare overall," says Professor Angela Wood. "But risks were generally higher and lasted longer after infection than after vaccination."
December 30, 2025 at 11:01 AM
"These complications are really rare overall," says Professor Angela Wood. "But risks were generally higher and lasted longer after infection than after vaccination."
The findings:
👉Children were far more likely to experience serious heart and inflammatory problems after catching COVID-19 than after being vaccinated
👉Blood clots increased after infection but not after vaccination
👉Health risks lasted much longer after infection
👉Children were far more likely to experience serious heart and inflammatory problems after catching COVID-19 than after being vaccinated
👉Blood clots increased after infection but not after vaccination
👉Health risks lasted much longer after infection
December 30, 2025 at 11:01 AM
The findings:
👉Children were far more likely to experience serious heart and inflammatory problems after catching COVID-19 than after being vaccinated
👉Blood clots increased after infection but not after vaccination
👉Health risks lasted much longer after infection
👉Children were far more likely to experience serious heart and inflammatory problems after catching COVID-19 than after being vaccinated
👉Blood clots increased after infection but not after vaccination
👉Health risks lasted much longer after infection